RecruitingNot ApplicableNCT06231732

The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study

The Impact of High-frequency Transcranial Alternating Current Stimulation (Hi-tACS) on Cognitive Function in Patients With Schizophrenia: a Pilot Study


Sponsor

Sir Run Run Shaw Hospital

Enrollment

12 participants

Start Date

Nov 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a double-blind, randomized, controlled intervention study aimed at exploring whether high-frequency transcranial alternating current stimulation (Hi-tACS) can improve cognitive impairment in patients with schizophrenia.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Meets the diagnostic criteria for schizophrenia according to DSM-5.
  • Age ≥ 18 years old.
  • Right-handed.
  • Willing to participate in this study and sign an informed consent form. If the participant is unable to read and sign the informed consent form due to lack of capacity, a legal guardian must act as a proxy during the informed consent process and sign the form.
  • Clinically stable, receiving antipsychotic medication treatment with a stable dose for 4 weeks without any changes.
  • Montreal Cognitive Assessment score ≥ 10 points.

Exclusion Criteria8

  • Psychotic disorders caused by split affective disorder, bipolar disorder, intellectual disability, anxiety spectrum disorders, drugs, alcohol, and other psychoactive substances according to DSM-V diagnostic criteria.
  • Those with severe or unstable organic diseases, with a history of brain tumors or epilepsy.
  • Those who have received MECT or TMS treatment within 1 month before enrollment.
  • Skin integrity at the electrode placement site is compromised. Allergy to electrode gel or adhesive.
  • Implants of metal or electronic devices (such as pacemakers, cochlear implants, deep brain stimulators, aneurysm clips, internal fixation devices after ventriculoperitoneal shunt surgery, etc.).
  • Participation in any other clinical trials within 1 month prior to baseline.
  • Pregnant and lactating women.
  • The investigator believes that there are inappropriate conditions for participating in this study.

Interventions

DEVICEhigh-frequency transcranial alternating current stimulation

The experimental group received real stimulation of high-frequency transcranial alternating current stimulation (Hi-tACS).The treatment duration is 30 days, with two sessions per day, each lasting 40 minutes.The experimental group received Hi-tACS with parameters set at 77.5Hz and 15mA

DEVICEsham high-frequency transcranial alternating current stimulation

The the control group received sham stimulation of high-frequency transcranial alternating current stimulation (Hi-tACS).The treatment duration is 30 days, with two sessions per day, each lasting 40 minutes.The experimental group received Hi-tACS with parameters set at 0mA


Locations(1)

Zhejiang Tongde Hospital

Hanzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06231732


Related Trials